ストックスクリーナーアプリを入手
35.01
0.26%
-0.09
Roivant Sciences Ltd (ROIV) 最新ニュース
Dimensional Fund Advisors LP Sells 1,771,602 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences Ltd. (ROIV) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bank of Nova Scotia Cuts Stake in Roivant Sciences Ltd. $ROIV - MarketBeat
Allspring Global Investments Holdings LLC Buys New Stake in Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences (ROIV) Edges Lower as Stock Consolidates Near Support ZoneInsider Sentiment - dars.gov.et
Roivant Sciences Ltd. (NASDAQ:ROIV) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
California Public Employees Retirement System Invests $19.15 Million in Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences Ltd. (ROIV) stock price, news, quote and history - Yahoo Finance UK
Roivant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026 - marketscreener.com
Roivant to Host Immunovant’s Aug. 6 Business Update Webcast - Stock Titan
Baader Bank Aktiengesellschaft Sells 33,612 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
Bank of New York Mellon Corp Decreases Stock Holdings in Roivant Sciences Ltd. $ROIV - MarketBeat
Form 4 Roivant Sciences Ltd. For: 21 July By Investing.com - Investing.com Nigeria
Form 4 Roivant Sciences Ltd. For: 21 July - Investing.com India
Roivant Sciences (ROIV) grants director Oren Ilan 775 fully vested shares - Stock Titan
Responsive Playbooks and the ROIV Inflection - Stock Traders Daily
Illinois Municipal Retirement Fund Boosts Stake in Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a 13.93% Upside in Biotech Innovation - DirectorsTalk Interviews
Why is Billionaire Joe Edelman Bullish on Roivant Sciences (ROIV) - Kavout | AI
Pfizer, BioNTech face global patent suits from Arbutus, Roivant over COVID vaccine tech - Seeking Alpha
Roivant unit Genevant, Arbutus file patent infringement suits against Pfizer, BioNTech over LNP technology - Bitget
ROIV Stock Nears Record High –Retail Traders See Breakout After Surprise Earnings Beat - Stocktwits
Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring the 9.47% Upside Potential in Biotech Innovation - DirectorsTalk Interviews
Roivant Sciences (ROIV) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary - Quartr
Roivant’s Gline: From spin-cos to commercial conviction - BioCentury
Roivant Sciences (ROIV) Climbs 2%: Biotech Stock Tests Key Resistance Near $38.65Moving Average Ribbon - dars.gov.et
Roivant Sciences (ROIV) TD Cowen 45th Annual Healthcare Conference Summary - Quartr
Roivant Sciences stock hits all-time high at 35.92 USD By Investing.com - Investing.com Nigeria
Roivant Sciences stock hits all-time high at 35.92 USD - Investing.com
Could Roivant Sciences Be a Multibagger Stock Over the Next 5 Years? - Yahoo Finance
Roivant Sciences Ltd. (ROIV) Stock Analysis: Potential Upside Amidst Biotech Innovations - DirectorsTalk Interviews
If You Invested $1,000 in Roivant Sciences (ROIV) - Stock Titan
ROIVRoivant Sciences Ltd Dividends - Finviz
Roivant Sciences Insider Sold Shares Worth $610,252, According to a Recent SEC Filing - Moomoo
Roivant Sciences (ROIV) director exercises options, sells 10,000 common shares - Stock Titan
Roivant Sciences (ROIV) Edges Lower, Consolidating Between Key Support and Resistance LevelsRegression Channel - dars.gov.et
Roivant Sciences (ROIV) Left Key Russell Indexes, Is It Still 10% Below Fair Value? - simplywall.st
Tax withholding trims Frank Torti’s Roivant Sciences (ROIV) share count - Stock Titan
Roivant Sciences (ROIV) director sells 17,750 shares after exercising options - Stock Titan
Roivant Sciences Insider Sold Shares Worth $56,444,076, According to a Recent SEC Filing - marketscreener.com
Roivant Sciences Insider Sold Shares Worth $49,354,076, According to a Recent SEC Filing - marketscreener.com
Roivant Sciences (ROIV) director-linked entity reports 1.44M-share open-market sale - Stock Titan
Form 144 ROIVANT SCIENCES LTD. For: 30 June - Investing.com UK
Roivant Sciences(ROIV.US) Director Sells US$56.44 Million in Common Stock - Moomoo
Roivant Sciences Director Sold Shares Worth Over $56M - TradingView
Form 144 ROIVANT SCIENCES LTD. For: 30 June By Investing.com - Investing.com Nigeria
Is Roivant Sciences (ROIV) Losing Its Defensive Status or Reframing Its Risk Narrative? - simplywall.st
Roivant Sciences Insider Sold Shares Worth $34,105,000, According to a Recent SEC Filing - Moomoo
Roivant Sciences Ltd.(NasdaqGS: ROIV) dropped from Russell 1000 Value-Defensive Index - marketscreener.com
Roivant Sciences Ltd.(NasdaqGS: ROIV) dropped from Russell 1000 Defensive Index - marketscreener.com
Roivant Sciences Ltd. (ROIV) Stock Analysis: A Biotech Powerhouse with 14.59% Potential Upside - DirectorsTalk Interviews
Roivant Sciences Insider Sold Shares Worth $6,631,268, According to a Recent SEC Filing - Moomoo
ROIV Q1 2026 Earnings: EPS Misses Estimates Amid R&D FocusSegment Revenue Breakdown - dars.gov.et
Understanding the Setup: (ROIV) and Scalable Risk - Stock Traders Daily
Price to sales forward of Roivant Sciences Ltd. – NASDAQ:ROIV - TradingView
0.32%
0.84%
大文字化:
|
ボリューム (24 時間):